Search

Bettear: one start-up’s journey to bridging a technological gap in pursuit of auditory accessibility

Imagine your disappointment if you have been looking forward to seeing your favourite grunge band play live at the Dog and Duck for weeks. Your family is bored of you constantly playing their greatest hits. But when you turn up...

My experience of implementing remote care during COVID-19

When the COVID-19 pandemic hit, it is safe to say very few audiology services were fully prepared for the challenges it would pose. Gina Angley, Associate Director Adult Amplification Program, Vanderbilt University, tells us about her experience of preparing her...

Developing an Innovation for ENT – from Idea to Market: how ‘e-i’ did it

Background endoscope-i (e-i) Ltd was incorporated into Companies House on December 3rd, 2012 following eight months of developing our first project, a simple iPhone adapter for endoscopes. Of the three founding shareholders, two are ENT surgeons and one a lecturer...

COVID-19 innovations

The coronavirus pandemic has mobilised medical innovators in an amazing way. We take a look at just a few of the hundreds of innovative products and techniques that have been developed and used in the last few weeks. Some of...

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

The workplace environment and doctors’ health (ENT)

It is well established that doctors have higher levels of stress, depression and suicide than the general population [1] and most other professional groups (Figure 1 illustrates the factors that can make us ill). In addition they have high levels...

NHS collaboration and partnership with the pharmaceutical and medical devices industries

Historically the relationship between industry and the NHS has been a cautious one. Both sides have typically worked with only partially disclosed agendas, under a pervading fear of finding themselves on the wrong end of a win-lose negotiation. Things have...

Taking life by the throat

Patients suffering with problems with their voice, airway and/or swallowing can find their symptoms immensely distressing, and their care places a huge burden on healthcare systems. We hear from a world-leading laryngologist on current and future directions. Field of interest...

Audiological monitoring in ototoxicity - Are we doing enough?

In this article Ghada Al-Malky explores the dichotomy of life-saving, yet hearing loss-causing medication, and questions whether the hearing healthcare community is doing enough to prevent preventable hearing loss. Ototoxicity is the damage to hearing and / or balance functions...